Trials / Completed
CompletedNCT04420806
Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women
Effects of Three Months of COVID-19 Lockdown Induced Deconditioning After 13 Months of High Intensity Exercise Training in Early Postmenopausal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Female
- Age
- 48 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
While "conditioning" by exercise training has been widely evaluated, the available literature on "passive deconditioning" (i.e. forced deconditioning) is predominately limited to studies with or with almost complete mechanical and/or metabolic immobilization/sedation of the respective functional system (e.g. paralysis, bedriddenness). Vice versa, the effects of moderately long interruptions of dedicated types of exercise while maintaining everyday activity are rarely addressed. However, this topic is of high relevance, e.g. considering that breaks of health-related exercise programs due to increased family/occupational stress, vacation or temporary orthopedic limitation are rather frequent in everyday life. In the present project we aimed to determine the effects of 3 months of physical deconditioning due to COVID-19 induced lockdown after 13 month of high intensity endurance and resistance exercise in early postmenopausal women on parameters related to health and physical fitness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | HIT-exercise | 13 months of high intensity endurance and resistance exercise, 3x 45 min/week - 3 months of COVID-19 induced exercise break |
| OTHER | Sham intervention | Types of exercise (flexibility, relaxation) that did not affect the present outcomes |
Timeline
- Start date
- 2020-03-14
- Primary completion
- 2020-07-30
- Completion
- 2020-10-30
- First posted
- 2020-06-09
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04420806. Inclusion in this directory is not an endorsement.